{"transactions":[{"id":1683534,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-08T18:14:29.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest in three equal annual installments beginning on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest in three equal annual installments beginning on January 5, 2025."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-003087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017024003087/ownership.xml","form_type":"4"}},{"id":1683533,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-08T18:14:29.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":50000,"derivative":{"exercise_price":10.56,"expiration_date":"2034-01-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-003087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017024003087/ownership.xml","form_type":"4"}},{"id":1683532,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-08T18:14:29.000Z","date":"2024-01-05","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on January 5, 2024."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000950170-24-003087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017024003087/ownership.xml","form_type":"4"}},{"id":1683531,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-08T18:14:29.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":1431,"price":11.2156,"value":16049.5236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory \"sell to cover\" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.49 to $11.58, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":6503,"source":{"system":"sec-edgar","filing":"0000950170-24-003087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017024003087/ownership.xml","form_type":"4"}},{"id":1683530,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-08T18:14:29.000Z","date":"2024-01-05","kind":"sale","planned":false,"acquired":false,"shares":4563,"price":10.6522,"value":48605.9886,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory \"sell to cover\" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.55 to $10.845, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":7934,"source":{"system":"sec-edgar","filing":"0000950170-24-003087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017024003087/ownership.xml","form_type":"4"}},{"id":1683529,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-08T18:14:29.000Z","date":"2024-01-05","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock issued upon vesting of one third of the restricted stock units (\"RSUs\") granted on January 5, 2023."}],"balance_after":12497,"source":{"system":"sec-edgar","filing":"0000950170-24-003087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017024003087/ownership.xml","form_type":"4"}},{"id":1715866,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-12-11T20:00:03.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":false,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs were granted on December 10, 2021 and vested in two equal annual instalments (on December 12, 2022 and December 11, 2023)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs were granted on December 10, 2021 and vested in two equal annual instalments (on December 12, 2022 and December 11, 2023)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1550},"source":{"system":"sec-edgar","filing":"0000950170-23-069496","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017023069496/ownership.xml","form_type":"4"}},{"id":1715865,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-11T20:00:03.000Z","date":"2023-12-11","kind":"sale","planned":false,"acquired":false,"shares":886,"price":9.1301,"value":8089.2686,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory \"sell to cover\" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.11 to $9.16, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":1997,"source":{"system":"sec-edgar","filing":"0000950170-23-069496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017023069496/ownership.xml","form_type":"4"}},{"id":1715864,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-11T20:00:03.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":true,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock issued upon vesting of one half of the restricted stock units (\"RSUs\") granted on December 10, 2021."}],"balance_after":2883,"source":{"system":"sec-edgar","filing":"0000950170-23-069496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000095017023069496/ownership.xml","form_type":"4"}},{"id":2059834,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-01-06T20:00:27.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three equal annual installments beginning on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three equal annual installments beginning on January 5, 2024."}],"balance_after":31500,"derivative":{"underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0000899243-23-001218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000089924323001218/doc4.xml","form_type":"4"}},{"id":2059833,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T20:00:27.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":47000,"derivative":{"exercise_price":8,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0000899243-23-001218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000089924323001218/doc4.xml","form_type":"4"}},{"id":2076516,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-12-23T20:00:22.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs were granted on December 10, 2021 and vest in two equal annual instalments beginning on December 12, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs were granted on December 10, 2021 and vest in two equal annual instalments beginning on December 12, 2022."}],"balance_after":1550,"derivative":{"underlying":"Common Shares","underlying_shares":1550},"source":{"system":"sec-edgar","filing":"0000899243-22-039332","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000089924322039332/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-14"}},{"id":2076515,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-23T20:00:22.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":887,"price":6.01,"value":5330.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (the \"Grant Agreement\"), effective on the grant date of the RSUs, the Reporting Person adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.99 to $6.035, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":1333,"source":{"system":"sec-edgar","filing":"0000899243-22-039332","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000089924322039332/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-14"}},{"id":2076514,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-23T20:00:22.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock issued upon vesting of one half of the restricted stock units (\"RSUs\") granted on December 10, 2021."}],"balance_after":2220,"source":{"system":"sec-edgar","filing":"0000899243-22-039332","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000089924322039332/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-14"}},{"id":2086031,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-12-14T20:00:27.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs were granted on December 10, 2021 and vest in two equal annual instalments beginning on December 12, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs were granted on December 10, 2021 and vest in two equal annual instalments beginning on December 12, 2022."}],"balance_after":1550,"derivative":{"underlying":"Common Shares","underlying_shares":1550},"source":{"system":"sec-edgar","filing":"0000899243-22-038516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000089924322038516/doc4.xml","form_type":"4"}},{"id":2086030,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-14T20:00:27.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":887,"price":6.01,"value":5330.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (the \"Grant Agreement\"), effective on the grant date of the RSUs, the Reporting Person adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.99 to $6.035, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":1333,"source":{"system":"sec-edgar","filing":"0000899243-22-038516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000089924322038516/doc4.xml","form_type":"4"}},{"id":2086029,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-14T20:00:27.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock issued upon vesting of one half of the restricted stock units (\"RSUs\") granted on December 10, 2021."}],"balance_after":2220,"source":{"system":"sec-edgar","filing":"0000899243-22-038516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1915257/000089924322038516/doc4.xml","form_type":"4"}},{"id":2337410,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":95362,"kind":"person","name":"Astle Christopher","position":1,"cik":"0001915257","reported_name":"Astle Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T21:00:23.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":125000,"derivative":{"exercise_price":7,"expiration_date":"2032-03-09","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-010796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924322010796/doc4.xml","form_type":"4"}}]}